Use in an animal host and precursors for vaccines utilizing avian-human reassortants to combat influenza A virus
US4552757A · kind A · utility
2Cited by
4References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 20, 1983 |
| Grant date | Nov 12, 1985 |
| Priority date | — |
| Expiry date | Dec 20, 2003 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/16161
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of producing a vaccine useful in animals which comprises producing a reassortment by gene exchange from an avian influenza A virus parent and an animal influenza A virus parent and then selecting for the reassortant containing two animal surface antigen genes and six avian internal genes by temperature and antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.